death-ligand

Explore academic connections and research related to this keyword

8
Views
16
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer?
Ceren Canbey; Sena Şen; Senem Karabulut; Tevhide Bilgen Özcan; Esra Paşaoğlu; Eren Altun; T. Kuzan;...
2025 cytojournal DOI: 10.25259/cytojournal... 15 views
2
MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma.
Liu, Zhuochao;Wen, Junxiang;Wu, Chuanlong;Hu, Chuanzhen;Wang, Jun;Bao, Qiyuan;Wang, Hongyi;Wang, Jiz...
2020 Aging DOI: 10.18632/aging.10267... 224 views
3
Next generation of anti-immune checkpoints antibodies
Bonnefoy, Nathalie;Olive, Daniel;Vanhove, Bernard;
2019 medecine sciences (paris) DOI: 10.1051/medsci/20191... 216 views
4
NFE2L2/KEAP1 mutations correlate with higher TMB value/PD-L1 expression and potentiate improved clinical outcome with immunotherapy.
Xu, Xian;Yang, Yang;Liu, Xiaoyan;Cao, Na;Zhang, Peng;Zhao, Songhui;Chen, Donglin;Li, Li;He, Yong;Don...
2020 the oncologist DOI: 10.1634/theoncologis... 246 views
5
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.
Maubec, Eve;Boubaya, Marouane;Petrow, Peter;Beylot-Barry, Marie;Basset-Seguin, Nicole;Deschamps, Lyd...
2020 journal of clinical oncology : official journal of... DOI: 10.1200/JCO.19.03357 182 views
6
Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
Lucia Musacchio;Serena Maria Boccia;Giuseppe Caruso;Giusi Santangelo;Margherita Fischetti;Federica...
2020 journal of clinical medicine DOI: 10.3390/jcm9061721 195 views
7
review of cancer immunotherapy: application of chimeric antigen receptor t cells and programmed death 1/programmed death-ligand 1 antibodies
;Tengfei Zhang;Ling Cao;Zhen Zhang;Dongli Yue;Yu Ping;Hong Li;Lan Huang;Yi Zhang
2015 cancer translational medicine DOI: 10.4103/2395-3977.15... 196 views
8
pulmonary sarcoidosis activation following neoadjuvant pembrolizumab plus chemotherapy combination therapy in a patient with non-small cell lung cancer: a case report
;Ghina Fakhri;Reem Akel;Ziad Salem;Ayman Tawil;Arafat Tfayli
2017 multi-span large bridges - proceedings of the inte... DOI: 10.1159/000484596 264 views
9
human cd8+cd28− t suppressor cells expanded by il-15 in vitro suppress in an allospecific and programmed cell death protein 1-dependent manner
;Fu Feng;Yanjun Liu;Guihuan Liu;Ping Zhu;Manman Zhu;Hua Zhang;Xiao Lu;Jiumin Liu;Xunrong Luo;Yuming...
2018 sudebno-meditsinskaia ekspertiza DOI: 10.3389/fimmu.2018.0... 171 views
10
immunotherapeutic strategies for gastric carcinoma: a review of preclinical and clinical recent development
;Mohamed Abozeid;Antonio Rosato;Roberta Sommaggio
2017 spectrochimica acta - part a: molecular and biomol... DOI: 10.1155/2017/5791262 151 views
11
evolving concepts: immunity in oncology from targets to treatments
;Hina Khan;Rasim Gucalp;Iuliana Shapira
2015 joule DOI: 10.1155/2015/847383
12
acquired natural killer cell dysfunction in the tumor microenvironment of classic hodgkin lymphoma
;Jodi Chiu;Daniel M. Ernst;Armand Keating
2018 sudebno-meditsinskaia ekspertiza DOI: 10.3389/fimmu.2018.0... 203 views
13
a case of poorly differentiated large-cell neuroendocrine carcinoma of the cecum: a rare malignancy, with review of the literature
;Andrew T. Mertz;Michelle A. Ojemuyiwa
2016 multi-span large bridges - proceedings of the inte... DOI: 10.1159/000452655 161 views
14
Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
Shifaa M. Abdin;Dana M. Zaher;El-Shaimaa A. Arafa;Hany A. Omar;Abdin, Shifaa M.;Zaher, Dana M.;Arafa...
2018 Cancers DOI: 10.3390/cancers10020... 214 views
15
Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri; Avik Maji; P. Potdar; Navneet Singh; P. Parikh; B. Bisht; Anubhab Mukherjee; M. Paul
2023 molecular cancer DOI: 10.1186/s12943-023-0... 11 views
16
Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.
Oh, Juhyun; Hoelzl, Jan; Carlson, Jonathan C T; Bill, Ruben; Peterson, Hannah M; Faquin, William C;...
2025 Cell reports. Medicine DOI: 10.1016/j.xcrm.2025.... 12 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

survival patients predictor subtypes different pancreatic positivity programmed poor histological cancer? pd-l1 immunosuppression pten cd8+ t cells microrna-200a adenosine chondrocytes chondrogenic progenitor cells immunologic factors